全文获取类型
收费全文 | 14339篇 |
免费 | 2178篇 |
国内免费 | 297篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 204篇 |
妇产科学 | 185篇 |
基础医学 | 1484篇 |
口腔科学 | 56篇 |
临床医学 | 1199篇 |
内科学 | 3739篇 |
皮肤病学 | 81篇 |
神经病学 | 369篇 |
特种医学 | 418篇 |
外国民族医学 | 1篇 |
外科学 | 409篇 |
综合类 | 930篇 |
现状与发展 | 6篇 |
预防医学 | 6358篇 |
眼科学 | 72篇 |
药学 | 722篇 |
4篇 | |
中国医学 | 89篇 |
肿瘤学 | 479篇 |
出版年
2024年 | 51篇 |
2023年 | 720篇 |
2022年 | 996篇 |
2021年 | 1042篇 |
2020年 | 1440篇 |
2019年 | 884篇 |
2018年 | 863篇 |
2017年 | 742篇 |
2016年 | 898篇 |
2015年 | 1078篇 |
2014年 | 1229篇 |
2013年 | 934篇 |
2012年 | 955篇 |
2011年 | 781篇 |
2010年 | 853篇 |
2009年 | 754篇 |
2008年 | 361篇 |
2007年 | 428篇 |
2006年 | 368篇 |
2005年 | 254篇 |
2004年 | 204篇 |
2003年 | 199篇 |
2002年 | 129篇 |
2001年 | 78篇 |
2000年 | 57篇 |
1999年 | 93篇 |
1998年 | 74篇 |
1997年 | 60篇 |
1996年 | 80篇 |
1995年 | 49篇 |
1994年 | 31篇 |
1993年 | 21篇 |
1992年 | 19篇 |
1991年 | 14篇 |
1990年 | 10篇 |
1989年 | 12篇 |
1988年 | 19篇 |
1987年 | 18篇 |
1986年 | 14篇 |
1984年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
141.
Wanitchaya Kittikraisak Podjanee Phadungkiatwatana Darunee Ditsungnoen Surasak Kaoiean Louis Macareo Kamonthip Rungrojcharoenkit Nattinee Srisantiroj Tawee Chotpitayasunondh Fatimah S. Dawood Joshua A. Mott Kim A. Lindblade 《Vaccine》2021,39(1):18-25
BackgroundWe compared cord blood antibody titers in unvaccinated pregnant women to those vaccinated with seasonal influenza vaccine during the 2nd and the 3rd trimesters.MethodsPregnant women had cord blood collected at delivery for hemagglutination inhibition assay against vaccine reference viruses: A/California/07/2009 (H1N1)pdm09, A/Switzerland/9715293/2013 (H3N2), and B/Phuket/3073/2013 (Yamagata lineage). Geometric mean titer (GMT) ratios were calculated comparing vaccinated versus unvaccinated pregnant women, and women vaccinated in the 2nd and the 3rd trimesters. Proportions of women achieving defined titers were compared using the χ2 test.ResultsOf 307 women, 190 (62%) were unvaccinated. Fifty and 67 were vaccinated during the 2nd and the 3rd trimesters, respectively. Median enrollment age was 29 years (interquartile range 24–34). Sixteen (5%) women had pre-existing conditions, but none were immunocompromised. GMT ratios comparing vaccinated and unvaccinated women were 5.90 (95% confidence interval [CI] 5.06–6.96) for influenza A/California, 5.39 (95% CI 4.18–6.08) for influenza A/Switzerland, and 5.05 (95% CI 4.43–5.85) for influenza B/Phuket. Similarly, the GMT ratios comparing the 3rd and the 2nd trimester vaccinated women were 2.90 (95% CI 2.54–3.39), 2.82 (95% CI 2.56–3.13), and 2.83 (95% CI 2.56–3.14), respectively. The proportions of women with defined titers for the three vaccine reference viruses did not differ between 2nd and 3rd trimester vaccinated women (titers ≥40: 68–92% versus 70–93%; ≥110: 32% versus 33–63%; and ≥330: 4–10% versus 3–21%).ConclusionsPregnant women vaccinated against influenza had more placental transfer of influenza antibodies to their infants than unvaccinated women. Placental transfer of antibodies was higher among those vaccinated in the 3rd trimester than in the 2nd trimester. There was no difference in the proportions of women achieving antibody titers corresponding to protection against influenza in children. Findings support the current World Health Organization’s recommendation that pregnant women may be vaccinated in either 2nd or 3rd trimester of pregnancy. 相似文献
142.
《Vaccine》2021,39(15):2133-2145
ObjectiveNoroviruses are the leading cause of acute gastroenteritis in the United States and outbreaks frequently occur in daycare settings. Results of norovirus vaccine trials have been promising, however there are open questions as to whether vaccination of daycare children would be cost-effective. We investigated the incremental cost-effectiveness of a hypothetical norovirus vaccination for children in daycare settings compared to no vaccination.MethodsWe conducted a model-based cost-effectiveness analysis using a disease transmission model of children attending daycare. Vaccination with a 90% coverage rate in addition to the observed standard of care (exclusion of symptomatic children from daycare) was compared to the observed standard of care. The main outcomes measures were infections and deaths averted, quality-adjusted life years (QALYs), costs, and incremental cost-effectiveness ratio (ICER). Cost-effectiveness was analyzed from a societal perspective, including medical costs to children as well as productivity losses of parents, over a two-year time horizon. Data sources included outbreak surveillance data and published literature.ResultsA 50% efficacious norovirus vaccine averts 571.83 norovirus cases and 0.003 norovirus-related deaths per 10,000 children compared to the observed standard of care. A $200 norovirus vaccine that is 50% efficacious has a net cost increase of $178.10 per child and 0.025 more QALYs, resulting in an ICER of $7,028/QALY. Based on the probabilistic sensitivity analysis, we estimated that a $200 vaccination with 50% efficacy was 94.0% likely to be cost-effective at a willingness-to-pay of $100,000/QALY threshold and 95.3% likely at a $150,000/QALY threshold.ConclusionDue to the large disease burden associated with norovirus, it is likely that vaccinating children in daycares could be cost-effective, even with modest vaccine efficacy and a high per-child cost of vaccination. Norovirus vaccination of children in daycare has a cost-effectiveness ratio similar to other commonly recommended childhood vaccines. 相似文献
143.
《Vaccine》2021,39(30):4219-4230
BackgroundDuring the 2009 influenza A(H1N1)pdm09 pandemic, 77 countries received donated monovalent A(H1N1)pdm09 vaccine through the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative. However, 47% did not receive their first shipment until after the first wave of virus circulation, and 8% did not receive their first shipment until after the WHO declared the end of the pandemic. Arguably, these shipments were too late into the pandemic to have a substantial effect on virus transmission or disease burden during the first waves of the pandemic.ObjectivesIn order to evaluate the potential benefits of earlier vaccine availability, we estimated the number of illnesses and deaths that could be averted during a 2009-like influenza pandemic under five different vaccine-availability timing scenarios.MethodsWe adapted a model originally developed to estimate annual influenza morbidity and mortality burden averted through US seasonal vaccination and ran it for five vaccine availability timing scenarios in nine low- and middle-income countries that received donated vaccine.ResultsAmong nine study countries, we estimated that the number of averted cases was 61–216,197 for actual vaccine receipt, increasing to 2,914–283,916 had vaccine been available simultaneously with the United States.ConclusionsEarlier delivery of vaccines can reduce influenza case counts during a simulated 2009-like pandemic in some low- and middle-income countries. For others, increasing the number of cases and deaths prevented through vaccination may be dependent on factors other than timely initiation of vaccine administration, such as distribution and administration capacity. 相似文献
144.
145.
146.
147.
148.
149.
目的 评估我国吸烟人群因吸烟所致内照射剂量并与其他国家进行比较。方法 收集并分析国内外香烟中210Po/210Pb辐射水平,推荐主流烟雾中210Po/210Pb份额,进行我国吸烟者因吸烟所致内照射剂量估算。结果 2015年中国15岁及以上成人现在吸烟者为3.2亿,日平均吸烟量为15.2支;按文献中香烟品牌数量加权的210Po /210Pb活度均值分别为28.2 mBq/支和39.3 mBq/支;在剂量估算中,210Po主流烟雾份额采用模拟装置和志愿者实验结果均值20%,210Pb主流烟雾份额采用模拟装置实验结果10%。根据我国日平均吸烟量和现在吸烟者人数估算的我国现在吸烟者年有效剂量为126 μSv·a-1,集体有效剂量为40746 人·Sv。结论 我国香烟中210Po/210Pb含量约为其它国家香烟的2~3倍,但由于本文采用的主流烟雾份额和210Po/210Pb剂量转换系数不同于其它文献,所以本文估算的我国吸烟人员吸20支烟所受剂量低于部分国家。 相似文献
150.